share_log

B. Riley Securities Maintains Buy on Abacus Life, Raises Price Target to $17

B. Riley Securities Maintains Buy on Abacus Life, Raises Price Target to $17

b. Riley证券维持对算盘人寿的买入评级,将目标股价上调至17美元
Benzinga ·  11/26 00:24  · 评级/大行评级

B. Riley Securities analyst Matt Howlett maintains Abacus Life (NASDAQ:ABL) with a Buy and raises the price target from $16 to $17.

b. Riley Securities 分析师马特·霍莱特维持Abacus Life (纳斯达克:ABL) 的买入评级,并将目标价从16美元上调至17美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发